Literature DB >> 8310831

Splenic hemangiosarcoma with sinus endothelial differentiation.

H Takato1, H Iwamoto, M Ikezu, N Kato, T Ikarashi, H Kaneko.   

Abstract

A case of primary splenic hemangiosarcoma where the tumors entirely replaced the spleen is reported. Histologically, the splenic tumors consisted of two major components: (i) solid and nodular areas, in which spindle cells (SC) were arranged in interlacing fascicles; and (ii) vasoformative areas, in which vascular lining cells (VC) closely resembled normal splenic sinus endothelial cells (SSEC) in shape. Both SC and VC were immunoreactive with the markers of vascular endothelial cells (EC) including SSEC, JC70, von Willebrand factor, OKM5, vimentin MAb and Ulex europaeus-1 lectin. The tumor cells were positive for OKM5 MAb as well as normal SSEC and sheathed arterial EC, but other vascular EC in normal spleen were negative. Enzyme-histochemically, the tumor cells and normal SSEC revealed naphthol AS-D acetate esterase activity but no reaction for ALPase, whereas normal vascular EC other than SSEC in the spleen were positive for the latter but negative for the former. These studies revealed that the tumor cells expressed the same phenotype as normal SSEC. To the present author's knowledge this is the first report demonstrating sinus endothelial differentiation of splenic hemangiosarcoma, enzyme- and immuno-histochemically.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8310831     DOI: 10.1111/j.1440-1827.1993.tb02556.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  3 in total

1.  [Vascular proliferations of the spleen].

Authors:  M Hartmann; A Marx; E Geissinger; H K Müller-Hermelink; T Rüdiger
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

Review 2.  Primary splenic angiosarcoma with liver metastasis: A case report and literature review.

Authors:  Kai-Feng Yang; Yong Li; De-Long Wang; Jun-Wu Yang; Sen-Yan Wu; Wei-Dong Xiao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

3.  Primary splenic angiosarcoma.

Authors:  Kamran S Hamid; Joaquin A Rodriguez; Terry C Lairmore
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.